Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: a mechanistic overview (2023)
- Authors:
- USP affiliated authors: SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; ROSSI, GIORDANO NOVAK - FMRP
- Unidade: FMRP
- DOI: 10.1177/02698811231200882
- Subjects: ALCALOIDES; ALUCINOGÊNICOS; TRANSTORNOS RELACIONADOS AO USO DE SUBSTÂNCIAS; SISTEMAS DE DISTRIBUIÇÃO DE MEDICAMENTOS
- Keywords: Iboga; Anti-addictive; Hallucinogen; Ibogaine; Noribogaine; Psychedelic; Substance use disorders
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Psychopharmacology
- ISSN: 0269-8811
- Volume/Número/Paginação/Ano: v. 37, n. 12, p. 1190-1200, 2023
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ONA, Genís et al. Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: a mechanistic overview. Journal of Psychopharmacology, v. 37, n. 12, p. 1190-1200, 2023Tradução . . Disponível em: https://doi.org/10.1177/02698811231200882. Acesso em: 27 dez. 2025. -
APA
Ona, G., Reverte, I., Rossi, G. N., Santos, R. G. dos, Hallak, J. E. C., Colomina, M. T., & Bouso, J. C. (2023). Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: a mechanistic overview. Journal of Psychopharmacology, 37( 12), 1190-1200. doi:10.1177/02698811231200882 -
NLM
Ona G, Reverte I, Rossi GN, Santos RG dos, Hallak JEC, Colomina MT, Bouso JC. Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: a mechanistic overview [Internet]. Journal of Psychopharmacology. 2023 ; 37( 12): 1190-1200.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1177/02698811231200882 -
Vancouver
Ona G, Reverte I, Rossi GN, Santos RG dos, Hallak JEC, Colomina MT, Bouso JC. Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: a mechanistic overview [Internet]. Journal of Psychopharmacology. 2023 ; 37( 12): 1190-1200.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1177/02698811231200882 - Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach
- The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials
- Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges
- Tripping to cope: coping strategies and use of hallucinogens during the COVID-19 pandemic in three cultural contexts
- Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic
- Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant
- The use of classic hallucinogens/psychedelics in a therapeutic context: healthcare policy opportunities and challenges
- Cross-sectional associations between lifetime use of psychedelic drugs and psychometric measures during the COVID-19 confinement: a transcultural study
- Polypharmacology or “pharmacological promiscuity” in psychedelic research: what are we missing?
- Therapeutic use of serotoninergic hallucinogens: a review of the evidence and of the biological and psychological mechanisms
Informações sobre o DOI: 10.1177/02698811231200882 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003200883.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
